Global Thoracic Outlet Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 161109
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 115
  • list Pharmaceuticals and Healthcare

Thoracic outlet syndrome is a group of heterogeneous and disabling upper-extremity disorders that occur due to extrinsic compression of neurovascular structures between the clavicle and the first rib. There are three distinct types of thoracic outlet syndrome viz. neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.

Scope of the Report:

Neurogenic thoracic outlet syndrome is most common, i.e., it constitutes around 85%-90% of thoracic outlet syndrome cases. Venous thoracic outlet syndrome constitutes around 10%-15% of thoracic outlet syndrome cases, whereas arterial thoracic outlet syndrome is found in 2%-5% of thoracic outlet syndrome cases.

The global Thoracic Outlet Syndrome Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Thoracic Outlet Syndrome Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Thoracic Outlet Syndrome Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Thoracic Outlet Syndrome Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers

Sanofi

Abbott

Bayer

Johnson & Johnson

Boehringer Ingelheim

Bristol-Myers Squibb

Daiichi Sankyo

Endo Pharmaceuticals

SteriMax

Upsher Smith Laboratories

Mallinckrodt

Orient Pharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Surgery

Medication

Physical Therapy

Others

Market Segment by Applications, can be divided into

Hospitals

Clinics

Diagnostic Centers

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Thoracic Outlet Syndrome Treatment Market Overview

1.1 Product Overview and Scope of Thoracic Outlet Syndrome Treatment

1.2 Classification of Thoracic Outlet Syndrome Treatment by Types

1.2.1 Global Thoracic Outlet Syndrome Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Thoracic Outlet Syndrome Treatment Revenue Market Share by Types in 2017

1.2.3 Surgery

1.2.4 Medication

1.2.5 Physical Therapy

1.2.6 Others

1.3 Global Thoracic Outlet Syndrome Treatment Market by Application

1.3.1 Global Thoracic Outlet Syndrome Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Diagnostic Centers

1.3.5 Others

1.4 Global Thoracic Outlet Syndrome Treatment Market by Regions

1.4.1 Global Thoracic Outlet Syndrome Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Thoracic Outlet Syndrome Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Thoracic Outlet Syndrome Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Thoracic Outlet Syndrome Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Thoracic Outlet Syndrome Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Thoracic Outlet Syndrome Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Thoracic Outlet Syndrome Treatment (2013-2023)

2 Manufacturers Profiles

2.1 Sanofi

2.1.1 Business Overview

2.1.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sanofi Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 Abbott

2.2.1 Business Overview

2.2.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Abbott Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bayer

2.3.1 Business Overview

2.3.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bayer Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Johnson & Johnson

2.4.1 Business Overview

2.4.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Johnson & Johnson Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 Boehringer Ingelheim

2.5.1 Business Overview

2.5.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Boehringer Ingelheim Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bristol-Myers Squibb

2.6.1 Business Overview

2.6.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bristol-Myers Squibb Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.7 Daiichi Sankyo

2.7.1 Business Overview

2.7.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Daiichi Sankyo Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.8 Endo Pharmaceuticals

2.8.1 Business Overview

2.8.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Endo Pharmaceuticals Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.9 SteriMax

2.9.1 Business Overview

2.9.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 SteriMax Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.10 Upsher Smith Laboratories

2.10.1 Business Overview

2.10.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Upsher Smith Laboratories Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.11 Mallinckrodt

2.11.1 Business Overview

2.11.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Mallinckrodt Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.12 Orient Pharma

2.12.1 Business Overview

2.12.2 Thoracic Outlet Syndrome Treatment Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Orient Pharma Thoracic Outlet Syndrome Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Thoracic Outlet Syndrome Treatment Market Competition, by Players

3.1 Global Thoracic Outlet Syndrome Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Thoracic Outlet Syndrome Treatment Players Market Share

3.2.2 Top 10 Thoracic Outlet Syndrome Treatment Players Market Share

3.3 Market Competition Trend

4 Global Thoracic Outlet Syndrome Treatment Market Size by Regions

4.1 Global Thoracic Outlet Syndrome Treatment Revenue and Market Share by Regions

4.2 North America Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

5 North America Thoracic Outlet Syndrome Treatment Revenue by Countries

5.1 North America Thoracic Outlet Syndrome Treatment Revenue by Countries (2013-2018)

5.2 USA Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

6 Europe Thoracic Outlet Syndrome Treatment Revenue by Countries

6.1 Europe Thoracic Outlet Syndrome Treatment Revenue by Countries (2013-2018)

6.2 Germany Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

6.4 France Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Thoracic Outlet Syndrome Treatment Revenue by Countries

7.1 Asia-Pacific Thoracic Outlet Syndrome Treatment Revenue by Countries (2013-2018)

7.2 China Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

7.5 India Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

8 South America Thoracic Outlet Syndrome Treatment Revenue by Countries

8.1 South America Thoracic Outlet Syndrome Treatment Revenue by Countries (2013-2018)

8.2 Brazil Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Thoracic Outlet Syndrome Treatment by Countries

9.1 Middle East and Africa Thoracic Outlet Syndrome Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Thoracic Outlet Syndrome Treatment Revenue and Growth Rate (2013-2018)

10 Global Thoracic Outlet Syndrome Treatment Market Segment by Type

10.1 Global Thoracic Outlet Syndrome Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Thoracic Outlet Syndrome Treatment Market Forecast by Type (2018-2023)

10.3 Surgery Revenue Growth Rate (2013-2023)

10.4 Medication Revenue Growth Rate (2013-2023)

10.5 Physical Therapy Revenue Growth Rate (2013-2023)

10.6 Others Revenue Growth Rate (2013-2023)

11 Global Thoracic Outlet Syndrome Treatment Market Segment by Application

11.1 Global Thoracic Outlet Syndrome Treatment Revenue Market Share by Application (2013-2018)

11.2 Thoracic Outlet Syndrome Treatment Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Clinics Revenue Growth (2013-2018)

11.5 Diagnostic Centers Revenue Growth (2013-2018)

11.6 Others Revenue Growth (2013-2018)

12 Global Thoracic Outlet Syndrome Treatment Market Size Forecast (2018-2023)

12.1 Global Thoracic Outlet Syndrome Treatment Market Size Forecast (2018-2023)

12.2 Global Thoracic Outlet Syndrome Treatment Market Forecast by Regions (2018-2023)

12.3 North America Thoracic Outlet Syndrome Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Thoracic Outlet Syndrome Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Thoracic Outlet Syndrome Treatment Revenue Market Forecast (2018-2023)

12.6 South America Thoracic Outlet Syndrome Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Thoracic Outlet Syndrome Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Thoracic Outlet Syndrome Treatment Picture

Table Product Specifications of Thoracic Outlet Syndrome Treatment

Table Global Thoracic Outlet Syndrome Treatment and Rev

Please fill the form below, to recieve the report sample


+1